24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2022
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2022 VC Survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Michael Levitt
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
16:00
Lightricks challenges AI giants with open-source text-to-video platform
19:28
Full list of Israeli high-tech funding rounds in 2024
19:24
TailorMed raises $40 million in equity and debt to help patients access critical medications
18:17
Why Israeli tech companies are moving to Miami
More stories
Buzz
Most popular
Daily
Weekly
1
Stars over Athens: The who’s who at Calcalist's first Israel-Greece conference
2
Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security
3
Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months
4
Mediaocean acquires Innovid for $500M, delisting it from the NYSE
5
Oracle CEO: "If we continue on our current trajectory, reaching a valuation of a trillion dollars is inevitable"
More news
Michael Levitt
2 stories about Michael Levitt
Michael Levitt Analysis: Corona Is Slowing Down, Humanity Will Survive
13.03.20
|
Ari Libsker
Nobel laureate and Stanford professor of Biology assures Israelis: statistics show the virus is on a downturn. Read more!
Paving the Way to Alzheimer’s Cure, One Algorithm at a Time
19.07.19
|
Tzipi Smilovitz
Israeli scientist Shahar Barbash is making waves in the pharmaceutical world with a new approach to image analysis that has even chemistry Nobel laureate Michael Levitt on board
Please ensure Javascript is enabled for purposes of
website accessibility